Masimo
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Masimo and other ETFs, options, and stocks.About MASI
Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its products include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet, Masimo Patient SafetyNet Surveillance, Masimo SafetyNet, Masimo SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridge.
MASI Key Statistics
Stock Snapshot
As of today, Masimo(MASI) shares are valued at $141.50. The company's market cap stands at 7.6B, with a P/E ratio of -13.86.
On 2025-11-18, Masimo(MASI) stock traded between a low of $141.50 and a high of $146.08. Shares are currently priced at $141.50, which is 0.0% above the low and -3.1% below the high.
Masimo(MASI) shares are trading with a volume of 161.85K, against a daily average of 1M.
In the last year, Masimo(MASI) shares hit a 52-week high of $194.88 and a 52-week low of $133.70.
In the last year, Masimo(MASI) shares hit a 52-week high of $194.88 and a 52-week low of $133.70.
MASI News
Needham analyst Michael Matson has maintained their neutral stance on MASI stock, giving a Hold rating today. Meet Your ETF AI Analyst Discover how TipRanks' ET...
In a report released yesterday, Marie Thibault from BTIG maintained a Buy rating on Masimo, with a price target of $198.00. Meet Your ETF AI Analyst Discover ho...
As previously reported, BofA analyst Travis Steed initiated coverage of Masimo (MASI) with a Neutral rating and $162 price target. Masimo’s flagship product, Si...
Analyst ratings
73%
of 11 ratingsMore MASI News
BofA initiated coverage of Masimo (MASI) with a Neutral rating and $162 price target Published first on TheFly – the ultimate source for real-time, market-movi...
A federal jury in California has ruled that Apple Inc. (NASDAQ:AAPL) must pay Masimo Corporation (NASDAQ:MASI) $634 million for infringing a patent related to b...
Masimo (MASI) issued the following statement in response to the jury verdict announced in the U.S. District Court for the Central District of California, which...
A federal jury in California ruled Friday that Apple must pay medical device maker Masimo $634 million for infringing a patent on blood oxygen monitoring techno...
Masimo Corporation recently reported third-quarter 2025 results, highlighting year-over-year sales growth to US$371.5 million but posting a net loss of US$100.4...
(RTTNews) - Masimo (MASI) announced that a jury in the U.S. District Court for the Central District of California has confirmed the validity of Masimo Patent No...
The U.S. International Trade Commission (ITC) has decided to start a new investigation into Apple’s (AAPL) latest Apple Watches to see if they should be banned...